Unveiling the roles of initial phase constituents and phase metastability in hydrogen embrittlement of TRIP‐assisted VCrCoFeNi medium‐entropy alloys

Medium-entropy alloys (MEAs) that exhibit transformation-induced plasticity (TRIP) from face-centered cubic (FCC) to body-centered cubic (BCC) are considered promising for liquid hydrogen environments due to their remarkable cryogenic strength. Nonetheless, studies on hydrogen embrittlement (HE) in BCC-TRIP MEAs have not been conducted, although the TRIP effect and consequent BCC martensite usually deteriorate HE susceptibility. In these alloys, initial as-quenched martensite alters hydrogen diffusion and trap behavior, and deformation-induced martensitic transformation (DIMT) provides preferred crack propagation sites, which critically affects HE susceptibility. Therefore, this study aims to investigate the HE behavior of BCC-TRIP MEAs by designing four V₁₀Cr₁₀Co₃₀Fe_50–xNi_x (x = 0, 1, 2, and 3 at%) MEAs, adjusting both the initial phase constituent and phase metastability. A decreased Ni content leads to a reduced fraction and mechanical stability of FCC, which in turn increases HE susceptibility, as determined through electrochemical hydrogen pre-charging and slow-strain rate tests The permeation test and thermal desorption analysis reveal that the hydrogen diffusivity and content are affected by initial BCC fraction, interconnectivity of BCC, and refined FCC. As these initial phase constituents differ between the alloys with FCC- and BCC- dominant initial phase, microstructural factors affecting HE are unveiled discretely among these alloy groups by correlation of hydrogen-induced crack behavior with hydrogen diffusion and trap behavior. In alloys with an FCC-dominant initial phase, the initial BCC fraction and DIMT initiation rate emerge as critical factors, rather than the extent of DIMT. For BCC-dominant alloys, the primary contributor is an increase in the initial BCC fraction, rather than the extent or rate of DIMT. The unraveled roles of microstructural factors provide insights into designing HE-resistant BCC-TRIP MEAs.